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Abstract Myeloperoxidase (MPO) is the most abundant
protein in neutrophils and plays a central role in microbial
killing and inflammatory tissue damage. Because most of the
non-steroidal anti-inflammatory drugs and other drugs contain a
thiol group, it is necessary to understand how these substrates are
oxidized by MPO. We have performed transient kinetic
measurements to study the oxidation of 14 aliphatic and
aromatic mono- and dithiols by the MPO intermediates,
Compound I (k3) and Compound II (k4), using sequential mixing
stopped-flow techniques. The one-electron reduction of Com-
pound I by aromatic thiols (e.g. methimidazole, 2-mercaptopur-
ine and 6-mercaptopurine) varied by less than a factor of seven
(between 1.39 þ 0.12U105 M31 s31 and 9.16 þ 1.63U105 M31
s31), whereas reduction by aliphatic thiols was demonstrated to
depend on their overall net charge and hydrophobic character and
not on the percentage of thiol deprotonation or redox potential.
Cysteamine, cysteine methyl ester, cysteine ethyl ester and K-
lipoic acid showed k3 values comparable to aromatic thiols,
whereas a free carboxy group (e.g. cysteine, N-acetylcysteine,
glutathione) diminished k3 dramatically. The one-electron
reduction of Compound II was far more constrained by the
nature of the substrate. Reduction by methimidazole, 2-
mercaptopurine and 6-mercaptopurine showed second-order rate
constants (k4) of 1.33 þ 0.08U105 M31 s31, 5.25 þ 0.07U105
M31 s31 and 3.03 þ 0.07U103 M31 s31. Even at high con-
centrations cysteine, penicillamine and glutathione could not
reduce Compound II, whereas cysteamine (4.27 þ 0.05U103
M31 s31), cysteine methyl ester (8.14 þ 0.08U103 M31 s31),
cysteine ethyl ester (3.76 þ 0.17U103 M31 s31) and K-lipoic acid
(4.78 þ 0.07U104 M31 s31) were demonstrated to reduce
Compound II and thus could be expected to be oxidized by
MPO without co-substrates.
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1. Introduction
Myeloperoxidase (MPO, EC 1.11.1.7) is a member of the
homologous mammalian peroxidase family that also includes
lactoperoxidase, eosinophil peroxidase, and thyroid peroxi-
dase. MPO is the most abundant protein of neutrophils (poly-
morphonuclear leukocytes) [1]. It is stored in their azurophilic
or primary granules and it is involved in killing invading
pathogens [2]. These granulocytic cells ingest microorganisms
into phagosomes where they kill them by generating an array
of reactive oxidants including superoxide and hydrogen per-
oxide. MPO is unique amongst the mammalian peroxidases in
its ability to utilize hydrogen peroxide in the oxidation of
chloride to hypochlorous acid. The potent cytotoxic action
of hypochlorous acid [3,4] and the demonstration that it is
produced inside phagosomes [5,6] underline the role of
MPO in killing invading pathogens. Hypochlorous acid is
also likely to contribute to the tissue damage caused by neu-
trophils at sites of in£ammation by inactivating enzymes,
cross-linking proteins, oxidizing susceptible amino acids, and
chlorinating lipids and tyrosyl residues [7]. MPO also cata-
lyzes the formation of hypothiocyanite at physiological con-
centrations of thiocyanate and chloride [8,9], and readily ox-
idizes numerous phenols, anilines and L-diketones to free
radicals [7]. In addition, it is capable of hydroxylating aro-
matic compounds [10].
With increasing frequency, MPO is being implicated in neu-
trophil-mediated tissue damage that occurs in in£ammatory
diseases such as rheumatoid arthritis, reperfusion injury, asth-
ma, in£ammatory bowel disease and cancer [11]. Interestingly,
most of the non-steroidal anti-in£ammatory drugs and other
drugs contain a thiol group (e.g. D-penicillamine and tiopro-
nin) and are widely used in the treatment of rheumatoid ar-
thritis [12,13] and related diseases. N-Acetylcysteine, mercap-
topropionylglycine and cysteamine were shown to act as
scavengers of hypochlorite in vivo [14^16], whereas the anti-
arthritic drug penicillamine and the antithyroid drug pro-
pylthiouracil were shown also to act as inhibitors of MPO
[17,18]. But their mode of action still remains uncertain.
Moreover, thiols are known to function as substrates for per-
oxidases [19^31]. Eqs. 1 and 3 and Eq. 4 summarize the con-
ventional peroxidase cycle with thiols (RSH) and/or thiolates
(RS3) as potential electron donors of the MPO intermediates
Compounds I and II:
PrxPHFeIII H2O2ÿ!k1 PrxPHcFeIV  OH2O 1
PrxPHcFeIV  OX3 Hÿ!k2 PrxPHFeIII HOX 2
PrxPHcFeIV  O RSHRS3ÿ!k3 PrxPHFeIV  O RSc
3
PrxPHFeIV  O RSHRS3ÿ!k4 PrxPHFeIII  RSc H2O
4
The cycle starts with the reaction of MPO with hydrogen
peroxide (H2O2) producing a two-electron oxidized species
known as Compound I in which the ferric iron (FeIII) is oxi-
dized to a ferryl species (FeIV = O) and the porphyrin (PH) to
a porphyrin radical cation (PrxPHc) (Eq. 1) [32]. This redox
intermediate oxidizes chloride and thiocyanate via a single
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two-electron reaction to produce the respective hypohalous
acids and regenerate the native enzyme (Eq. 2). Alternatively,
stepwise reduction of Compound I by two thiol-derived elec-
trons produces Compound II, in which the porphyrin radical
cation has been quenched (PrxPHFeIV = O), and subsequently
the resting ferric state (PrxPHFeIII). The formation of thiyl
radicals has been demonstrated by electron spin resonance
spectroscopy for thiol oxidation by horseradish peroxidase
(HRP) [33,34], lactoperoxidase [35] and MPO [21].
Thiyl radicals show a very complex behavior in aqueous
solutions undergoing conjugative reactions [30,31]. These
non-enzymatic free radical reactions have the consequence
that thiol oxidation is accompanied by oxygen consumption,
superoxide formation and regeneration of hydrogen peroxide
[30,31]. Characterization of the overall reaction makes it nec-
essary to di¡erentiate between the enzymatic (Eqs. 1 and 3
and Eq. 4) and the non-enzymatic free radical reactions, be-
cause the fate of thiyl radicals is strongly in£uenced by the
kinetics of reactions that produce and remove them.
To fully appreciate the mode of action of thiol containing
(anti-in£ammatory) drugs it will be necessary to understand
how these substrates are oxidized by MPO. In this investiga-
tion we have carried out transient-state kinetic studies to elu-
cidate relationships between the structure of thiols and their
abilities to react with MPO. For the ¢rst time a comprehen-
sive sequential-stopped-£ow investigation is presented com-
paring 14 aliphatic and aromatic mono- and dithiols for their
ability to function as electron donors for Compound I (k3)
and Compound II (k4) of human MPO. Moreover, the pH
dependence of both k3 and k4 is presented.
2. Materials and methods
2.1. Materials
MPO was puri¢ed from human neutrophils to a purity index (A430/
A280) of at least 0.86 as described by Kettle and Winterbourn [36]. Its
concentration was calculated using O430 = 91 000 M31 cm31 per heme
[37] and was given in mol per heme per liter. Hydrogen peroxide,
obtained from a 30% solution from Sigma Chemical Co., was diluted
and the concentration determined by absorbance measurement at 240
nm where the extinction coe⁄cient is 39.4 M31 cm31 [38]. The other
chemicals (L-cysteine, L-cysteamine, DL-penicillamine, DL-homocys-
teine, N-acetyl-L-cysteine, L-cysteine methyl ester, L-cysteine ethyl es-
ter, glutathione, DL-K-lipoic acid, 2,3-dimercaptopropanol, 4-thiouri-
dine, 2-mercaptopurine, 6-mercaptopurine, methimidazole and
homovanillic acid) were also purchased from Sigma Chemical Co.
at the highest grade available. All other chemicals were of analytical
grade.
Thiol solutions were always prepared fresh and bubbled with nitro-
gen before use. All reactions were performed in bu¡ers containing 100
WM of the metal ion chelator diethylene-triaminepentaacetic acid
(DTPA) which is known to prevent thiol autoxidation [39]. For con-
trol, actual aliphatic thiol concentrations were determined according
to [31], but this method has been established to be not applicable to
aromatic thiols.
2.2. Methods
Sequential stopped-£ow measurements were performed with an Ap-
plied Photophysics (UK) instrument (model SX-18MV). When 100 Wl
was shot into a £ow cell having a 1 cm light path, the fastest time for
mixing two solutions and recording the ¢rst data point was approx-
imately 1.5 ms. Multi-mixing analysis was used for kinetic measure-
ments of both the conversion of Compound I to Compound II and
the conversion of Compound II to the native enzyme. Compound I is
inherently unstable [40]. With 0.5 WM MPO, 5 WM was the minimum
hydrogen peroxide concentration required for complete formation of
Compound I (characterized by a 50% hypochromicity in the Soret
band at 430 nm). Under these conditions, Compound I was com-
pletely formed within 20 ms and was stable for at least a further 30
ms. In a typical experiment, 2 WM ferric MPO was premixed in the
ageing loop with 20 WM hydrogen peroxide for 25 ms. Compound I
was then allowed to react with varying concentrations of thiols. Re-
actions were carried out in 100 mM sodium/potassium phosphate
bu¡er (pH 7.0) containing 100 WM DTPA and monitored at 456
nm. To ensure ¢rst-order kinetics, ¢nal thiol concentrations were at
least 10 times that of the enzyme. At least three determinations of
kobs, the pseudo-¢rst-order rate constant, were performed for each
substrate concentration. Second-order rate constants were calculated
from the slope of the plot of the mean kobs values versus substrate
concentration.
Reduction of Compound II by the thiols was measured as described
in [41]. For its determination, 2 WM ferric MPO was premixed with 20
WM hydrogen peroxide and 1.8 WM homovanillic acid (HVA) in the
ageing loop. Under these conditions, Compound II was stable for at
least 100 s. 40 s after the initial mixing, Compound II was allowed to
react with a substrate. To ensure ¢rst-order kinetics, the ¢nal concen-
trations of the thiols were at least 10 times that of the enzyme. Re-
actions were carried out in 100 mM sodium/potassium phosphate
bu¡er (pH 7.0) containing 100 WM DTPA and were monitored by
recording the loss in absorbance at 456 nm. At least three determi-
nations of the pseudo-¢rst-order rate constants, kobs, were performed
for each substrate concentration and the mean value was used to
calculate k4 as described above.
To determine the pH dependence of the reduction of Compound I,
the sequential stopped-£ow experiments were performed at di¡erent
pH values from 4.0 to 9.0. In a typical pH jump experiment 2 WM
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Table 1
Summary of bimolecular rate constants for reactions of myeloperoxidase Compound I (k3) and Compound II (k4) with aliphatic and aromatic
thiols at pH 7.0
Thiol pKa;NH3 pKa;SH % [RS
3] at pH 7.0a Net charge at pH 7.0 k3 [M31 s31] k4 [M31 s31]
Cysteine 10.8 8.3 4.8 30.05 4.10 þ 0.10 E+3 6 1 E+1
Cysteamine 10.8 8.6 2.5 + 0.98 1.65 þ 0.04 E+5 4.27 þ 0.05 E+3
Penicillamine 10.4 7.9 11.2 30.11 2.64 þ 0.18 E+3 6 1 E0
N-Acetylcysteine ^ 9.5 0.3 31.00 4.56 þ 0.04 E+2 4.76 þ 0.26 E+2
Homocysteine 10.9 8.9 1.2 30.01 1.38 þ 0.11 E+3 6.00 þ 0.32 E+2
Cysteine methyl ester 9.0 6.6 71.5 +0.27 2.49 þ 0.04 E+5 8.14 þ 0.08 E+3
Cysteine ethyl ester 9.2 6.7 66.6 +0.33 2.15 þ 0.04 E+5 3.76 þ 0.17 E+3
Glutathione 9.7 8.8 1.6 31.02 7.21 þ 0.40 E+1 6 1 E0
Methimidazole ^ ^ ^ ^ 9.16 þ 1.63 E+5 1.33 þ 0.08 E+5
4-Thiouridine ^ ^ ^ ^ 6.79 þ 0.22 E+3 4.05 þ 0.10 E+2
2-Mercaptopurine ^ ^ ^ ^ 9.02 þ 1.26 E+5 5.25 þ 0.07 E+5
6-Mercaptopurine ^ 7.8 13.7 30.14 1.39 þ 0.13 E+5 3.03 þ 0.07 E+3
2,3-Dimercaptopropanol ^ ^ ^ ^ ^ 5.77 þ 0.04 E+5
K-Lipoic acid ^ 10.7 0.0 31.00 7.75 þ 0.24 E+4 4.78 þ 0.07 E+4
For details concerning sequential-stopped-£ow spectroscopy see Section 2. Data for pKa;NH3 and pKa;SH are taken from [43]. Calculation of
percentage thiolate at pH 7.0 is indicated.
aThe fraction of RSH in the thiolate form (RS3) has been calculated by [RS3]/([RS3]+[RSH]) = [1+10pK3pH]31.
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MPO in 5 mM sodium/potassium phosphate bu¡er (pH 7.0) was
premixed with 20 WM H2O2 in distilled water. After a delay time of
25 ms, Compound I was allowed to react with varying concentrations
of thiols in 200 mM phosphate/citrate bu¡er (pH 4^7) or HEPES/Tris
(pH 7^9), both containing 200 WM DTPA. For reduction of Com-
pound II, 2 WM MPO in 5 mM phosphate bu¡er (pH 7.0) was pre-
mixed with 20 WM H2O2 in distilled water containing 1.8 WM HVA.
After a delay time of 40 s, Compound II was allowed to react with
varying concentrations of thiols in 200 mM phosphate/citrate bu¡er
(pH 4^7) or HEPES/NaOH (pH 7^9), both containing 200 WM
DTPA. All stopped-£ow investigations were performed at 15‡C.
Rapid spectral scans of MPO and its intermediates during reaction
were conducted by taking time-dependent spectra from single-wave-
length shots. The spectra generated from the rapid scans were recon-
structed using the GLint application software from Applied Photo-
physics.
3. Results and discussion
In the present paper, structure-activity relationships of 14
thiols as MPO substrates have been investigated. In previous
studies [21^24,26,28,29] only indirect methods (i.e. disul¢de
formation, ESR techniques and superoxide radical formation)
were employed to measure thiol oxidation. But they are prob-
lematic in interpreting structure-activity relationships, because
during thiol oxidation oxygen activation by thiyl radical re-
actions takes place leading to the formation of superoxide and
hydrogen peroxide [30,31] which themselves are involved in
both the enzyme activity (i.e. Compound I formation) and
inactivation [7]. Therefore, it is necessary to know the actual
rates of thiyl radical formation which in£uence both the na-
ture and rate of the thiyl radical reactions [30]. Here we
present for the ¢rst time actual bimolecular rates of the reac-
tion between thiols and both higher oxidation states of MPO,
namely Compound I (k3) and Compound II (k4).
In contrast to HRP [42], Compound I of human MPO is
very unstable and spontaneously decays to its one-electron
reduction product, Compound II. Fig. 1A shows the spectra
of the relevant enzyme intermediates formed upon addition of
a 10-fold excess of hydrogen peroxide to the native enzyme.
The spectra were generated from a sequence of kinetic records
collected at a series of monochromator wavelengths between
400 and 480 nm at 2 nm intervals. In Fig. 1A the points in
time at which the slices across these records were taken are at
0 ms (spectrum 1, representing native enzyme), 20 ms (spec-
trum 2, Compound I) and 20 s (spectrum 3, Compound II)
after the £ow had stopped.
With our MPO preparations (RZs 0.86) a minimum of 10-
fold excess of hydrogen peroxide was necessary for complete
formation of Compound I. A larger excess brought a stronger
interference with Compound I reduction by H2O2, which is
known to function as electron donor for Compound I [40].
The conversion of native MPO to Compound I displaying a
monophasic exponential character was completed within 20
ms (Fig. 1B). Before its decay it was mixed (arrow in Fig.
1B) with varying concentrations of thiols.
A typical kinetic time trace for Compound I reduction by
cysteamine is shown in the inset of Fig. 2A. It displays a
single-exponential character. The corresponding pseudo-¢rst-
order rate constants were obtained from these traces and plot-
ted against the concentration of cysteamine. From the slope of
this secondary plot the apparent second-order rate constant
(k3) was calculated to be 1.65 þ 0.04U105 M31 s31 at pH 7.0
and 15‡C. The corresponding k3 values of the other thiols
investigated are summarized in Table 1 and demonstrate the
e¡ect of thiol structure on Compound I reduction.
On insertion of a carboxy group into cysteamine (cysteine),
k3 decreased dramatically (4.10 þ 0.10U103 M31 s31). The
cysteine homologue, homocysteine, showed 34% of the activ-
ity of cysteine, whereas insertion of methyl groups at the
carbon atom close to the mercapto group in cysteine (penicill-
amine) led to a 36% decrease of k3 compared with cysteine. N-
Acetylation of cysteine further decreased k3 (4.56 þ 0.04U102
M31 s31) and cysteine as part of the tripeptide glutathione
proved to be an extremely poor electron donor for Compound
I. However, upon esteri¢cation of cysteine a dramatic increase
of k3 was observed. The reaction of Compound I with cys-
teine methyl ester and cysteine ethyl ester was even faster than
with cysteamine, namely 51% and 30%, respectively. We have
also investigated the electron donor capacity of two aliphatic
dithiols. Compared with cysteine, K-lipoic was shown to react
19 times faster. Interestingly, reduction of Compound I by
2,3-dimercaptopropanol was biphasic and in contrast to its
reaction with Compound II, which displayed a monophasic
behavior, extremely slow. Since we do not understand this
behavior at the moment, we have not included k3 for 2,3-
dimercaptopropanol in Table 1.
Aromatic thiols proved to be good electron donors for
Compound I. With the exception of thiouridine, the magni-
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Fig. 1. A: Rapid-scan spectra of native myeloperoxidase (1) and
after adding 10-fold excess H2O2. The spectra were taken (2) 20 ms
and (3) 20 s after the £ow had stopped. Arrows show the direction
of absorbance changes with time. Final enzyme concentration: 1 WM
in 100 mM phosphate bu¡er, pH 7.0. B: Typical time traces of this
reaction followed at 430 nm (Compound I formation). The inset
shows Compound II formation at 456 nm upon adding 10-fold
H2O2 and substoichiometric homovanillic acid to native MPO. The
arrows indicate the delay time used in the sequential mixing
stopped-£ow experiments.
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tudes of the corresponding k3 values varied by less than a
factor of seven (1.4^9.2U105 M31 s31) and are comparable
with tyrosine as electron donor [44].
There were ¢nite intercepts for the secondary plots of kobs
for Compound I reduction versus the concentration of thiols
(Fig. 2A). Their magnitudes were dependent on the nature of
the substrate (not shown) and indicated the existence of reac-
tions which also contribute to absorbance changes at 456 nm,
i.e. both the spontaneous reduction of Compound I by excess
hydrogen peroxide and/or the reduction of Compound II by a
second substrate molecule. With the exception of methimid-
azole, the intercepts of aromatic thiols varied between 1.6 and
4.8 s31 (not shown) which is in good agreement with those
determined previously for aromatic electron donors [41,44].
Methimidazole showed a relatively high intercept of about
30 s31. It is known to be an irreversible, mechanism-based
inhibitor of thyroid peroxidase and lactoperoxidase [45]. Since
MPO is a better catalyst than thyroid peroxidase and lacto-
peroxidase with most of the substrates investigated so far
[25,44], it is very likely that a reaction, which was part of
the MPO inactivation mechanism, was responsible for this
high intercept value. With aliphatic thiols the intercept values
varied between 0.8 and 3.4 s31 (not shown).
Formation of Compound II and measuring of its reduction
is problematic. When Compound II formation occurs by ex-
cess hydrogen peroxide [40], the enzyme is likely to cycle when
the reducing substrate is added. Recently, we have described a
method for measuring Compound II reduction under pre-
steady-state conditions [41]. We premixed a 10-fold excess of
hydrogen peroxide and sub-stoichiometric concentrations of
homovanillic acid to generate Compound II (inset of Fig.
1B), and then followed its reactions by adding the thiol after
a delay time of 40 s (arrow in the inset of Fig. 1B). With each
thiol, the loss of absorbance at 456 nm displayed single ex-
ponential character. A typical time trace for the reaction of
cysteamine and methimidazole with Compound II is shown in
the insets of Figs. 3A and 4A, respectively. The apparent
second-order rate constants for the reduction of Compound
II (k4) were obtained from secondary plots (Figs. 3A and 4A)
and were calculated for cysteamine and methimidazole to be
4.27 þ 0.05U103 M31 s31 and 1.33 þ 0.08U105 M31 s31, re-
spectively, at pH 7.0 and 15‡C. Reduction of Compound II by
thiols is far more constrained by the nature of the thiols than
Compound I reduction. Even at high thiol concentrations,
cysteine, penicillamine and glutathione were incapable of re-
ducing Compound II. N-Acetylcysteine and homocysteine re-
acted poorly with Compound II, but cysteamine, cysteine
methyl ester (8.14 þ 0.08U103 M31 s31) and cysteine ethyl
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Fig. 3. A: Pseudo-¢rst-order rate constants for Compound II reduc-
tion by cysteamine. The inset shows a typical time trace followed at
456 nm using sequential mixing mode. Final concentrations were
0.5 WM MPO, 5 WM H2O2, 0.45 WM HVA and 25 mM cysteamine
in 100 mM phosphate bu¡er (pH 7.0) containing 100 WM DTPA at
15‡C. B: The pH pro¢le for reduction of Compound II by cyste-
amine (1) and cysteine methyl ester (2). Conditions were as de-
scribed in A except that the bu¡ers used were phosphate/citrate
bu¡er (pH 4^7) or HEPES/Tris (pH 7^9), both containing 100 WM
DTPA.
Fig. 2. A: Pseudo-¢rst-order rate constants for Compound I reduc-
tion by cysteamine. The inset shows a typical time trace followed at
456 nm using sequential mixing mode. Final concentrations were
0.5 WM MPO, 5 WM H2O2 and 10 WM cysteamine in 100 mM phos-
phate bu¡er (pH 7.0) containing 100 WM DTPA at 15‡C. B: The
pH pro¢le for reduction of Compound I by cysteamine (1) and cys-
teine methyl ester (2). Conditions were as described in A except that
the bu¡ers used were phosphate/citrate bu¡er (pH 4^7) or HEPES/
Tris (pH 7^9), both containing 100 WM DTPA.
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ester (3.76 þ 0.17U103 M31 s31) reacted at acceptable rates
and could be expected to be oxidized by the enzyme. This is
consistent with the ¢ndings of Svensson and coworkers [25,28]
who investigated the ability of MPO to oxidize aliphatic ami-
nothiols in the absence of hydrogen peroxide using steady-
state spectroscopy and polarographic measurements of oxy-
gen consumption. They found that only cysteamine and cys-
teine esters could be oxidized by MPO and consequently, by
the reactions of thiyl radicals, generate hydrogen peroxide in
order to maintain the peroxidatic cycle. Interestingly, both
aliphatic dithiols proved to be very e⁄cient in reduction of
Compound II. Their corresponding k4 values were of the same
order of magnitude as those calculated for the aromatic thiols
and for tyrosine [44].
Our study further revealed, that at physiological pH MPO
is an active catalyst of thiol oxidation. Fig. 2B shows the pH-
dependence of the apparent second-order rate constants for
the reaction of Compound I with cysteamine and cysteine
methyl ester. Reaction of Compound I with cysteine methyl
ester was favored between pH 7 and 7.5, whereas, in the pH
range investigated, the corresponding k3 values for cysteamine
increased with increasing pH. Considering the di¡erent pKa;SH
values of cysteamine and cysteine methyl ester (i.e. 8.6, and
6.6, respectively) [43], a possible explanation for the observed
di¡erences in pH dependence between these thiols could not
be that the thiolate anion form is the actual substrate for
MPO. This is underlined by the similar pH pro¢les of Com-
pound II reduction by cysteamine and cysteine methyl ester
showing a maximum of activity between pH 7 and 7.5 (Fig.
3B). On the contrary, with methimidazole k4 slightly increased
by decreasing pH (Fig. 4B).
In conclusion, both Compound I and Compound II of
MPO are able to react with aliphatic and aromatic thiols
via one-electron oxidations and therefore generate thiyl radi-
cals. Compared with phenols (e.g. tyrosine [44]) aromatic thi-
ols were shown to have similar electron donor capacities,
whereas the structural requirements for aliphatic thiols to
function as electron donors for MPO are more restricted.
Compared with the reaction rate of Compound I reduction
by chloride [9], the major physiological substrate of MPO,
aromatic thiols, cysteamine, both cysteine esters and K-lipoic
acid proved to be better electron donors than the halide. The
di¡erences in the redox potentials between the thiols are too
low to be used to answer the questions concerning the di¡er-
ing reactivity of aliphatic thiols [46] and our experiments
about the pH dependence of k3 and k4 demonstrated unequiv-
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Table 2
Schematic formulas of the thiol compounds
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ocally that the portion of thiolate at a de¢ned pH did not
have an impact on reactivity. Nevertheless, the overall net
charges of the thiols are likely to be more important for re-
action (see Table 2) than the actual size of the substrate. This
was best demonstrated by appreciating the actual rates when
going from cysteamine to cysteine and ¢nally cysteine methyl
ester. These structure-activity relationships of the aliphatic
thiols suggest the existence of a negatively charged group
(e.g. carboxy group) either in the substrate channel or at the
active site of MPO, which hampers the reaction with sub-
strates containing a negatively net charge (cysteine, homocys-
teine, N-acetylcysteine, penicillamine and glutathione). In-
creasing the hydrophobic character of the potential electron
donor diminished these constraints (e.g. K-lipoic acid), which
goes well together with the known overall hydrophobic char-
acter of the entrance to the distal cavity of MPO which favors
interaction with aromatic molecules [47].
While all hemoprotein peroxidases are generally considered
to catalyze oxidation reactions in a similar manner, a compar-
ison of the rate constants for thiol oxidation between MPO
and HRP [31] re£ects di¡erences in the e¡ectiveness of reac-
tivity. Compared with MPO Compound I, HRP Compound I
is a less e¡ective catalyst for thiol oxidation. This is consistent
with the high oxidation potential of MPO Compound I [32]
which enables the enzyme even to oxidize chloride. The bimo-
lecular rate constants for the reaction of MPO Compound I
are 1^2 orders of magnitude higher than the corresponding
reactions catalyzed by HRP Compound I [31]. Thus MPO
Compound I should be able to oxidize a wide range of organ-
ic substrates. In contrast, MPO Compound II will be far more
constrained by the nature of the aliphatic thiols, when com-
pared with the corresponding rates published for HRP [9].
With both peroxidases, cysteine, penicillamine and gluta-
thione were unable to reduce Compound II. But in contrast
to the corresponding reactions with HRP Compound II, the
reactivity of cysteamine, 2,3-dimercaptopropanol, K-lipoic
acid proved to be about 100 times higher, which was also
the case when aromatic thiols functioned as electron donors
of MPO Compound II.
Our results could help to understand the mechanism of
action of thiol containing drugs used in the treatment of dis-
eases where MPO is thought to be involved. Anti-in£amma-
tory drugs of aromatic character are likely to be oxidized by
the enzyme, whereas the oxidation of aliphatic drugs depends
on structural requirements which have been demonstrated in
the present work. Drugs that react poorly with Compound II
(i.e. penicillamine) would not be expected to be oxidized by
the enzyme. However, in the presence of suitable co-substrates
that readily reduce Compound II, such as tyrosine or ascor-
bate [44,48], the high oxidation potential of Compound I
could be exploited to catalyze the oxidation of even these
thiols.
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